Clinical Trial Update: Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating valproate (Depakine Chrono) for mania in bipolar disorder in the Gulf region has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Depakine Chrono (valproate)

Snippet

Sponsor: Sanofi | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED